When assessing the potential impact of ABCB1 polymorphisms on the development of DILI in TB-HIV co-infected patients receiving efavirenz and RIF-containing regimens, Yimer and colleagues showed that the rs1045642 GG genotype increased susceptibility to hepatotoxicity independently of concomitant RIF use [32]. This evidence concerns the gene ABCB1 and tuberculosis.